Gen X and Millennials face three to four times higher appendix cancer risk than before

A rare form of cancer is climbing at an alarming rate among younger generations, leaving scientists without a clear explanation for why it is happening.

New research from the United States has revealed that Gen X-ers and Millennials are three to four times more likely than older generations to receive a diagnosis of appendix cancer — a malignancy affecting the small, finger-shaped organ attached to the digestive tract that most people only consider when it causes problems.

A condition once confined to older patients

Historically, appendix cancer was almost exclusively a disease of older adults. Today, however, one in every three patients diagnosed with the condition is under the age of 50 — a dramatic demographic shift that has prompted serious scientific concern.

Epidemiologist and molecular biologist Andreana Holowatyj of Vanderbilt University has spent years tracking this generational rise and is determined to uncover its cause.

"When we think about the significant progress we've made in other cancers, there's a big gap," she said in 2024.

Her earlier work, published in 2020, led a national analysis that found malignant appendix cancer diagnoses in the US rose by 232 per cent between 2000 and 2016 — with every generation recording an increase.

The appendix: not as useless as once thought

For a long time, the appendix was widely regarded as a vestigial organ — a biological remnant with no meaningful purpose. More recent evidence, however, suggests that view may have been premature.

Appendicitis, or inflammation of the appendix, remains the organ's most common associated complication, and cancer is occasionally discovered when the appendix is removed as a result.

Symptoms that are easy to miss or misread

The progression of appendix cancer is often insidious. Its warning signs — including abdominal pain, bloating and pelvic pain — are easily confused with far more prevalent conditions such as digestive complaints or colorectal cancer, which affects roughly 150,000 Americans each year. By contrast, appendix cancer accounts for only around 3,000 cases annually in the US, a relatively low figure that has contributed to limited research funding and public awareness.

"Albeit cancer of the appendix is rare, it is important for individuals who have these symptoms to see a health care professional," Holowatyj said.

"Ruling out the possibility of an appendix cancer diagnosis, or diagnosing it early, is important for this cancer as we continue to learn what factors may be contributing to this worrisome trend," she added.

There are currently no standardised screening guidelines for the condition, and available treatment options remain limited. The cancer can also be difficult to detect, particularly as non-surgical management of appendicitis becomes more common. It can present in ways that resemble hernias, fibroids or cysts, and in women it is sometimes mistaken for endometrial lesions.

"Appendiceal tumors harbor different molecular features from colorectal cancers," Holowatyj explained in 2020.

"They present and spread differently, don't respond to the chemotherapy most colorectal tumors do, and they disproportionately affect younger adults," she added.

The generational data in sharp focus

Holowatyj and her team's most recent research found that cases of appendix cancer tripled among Americans born between 1976 and 1984, relative to those born between 1941 and 1949. For those born between 1981 and 1989, the figure quadrupled.

The reasons behind this trend remain unclear. Holowatyj and her colleagues believe that shifts in health behaviours — such as changes in diet and physical activity — alongside inherited genetic variants and potential environmental exposures, including plastic and chemical pollution, may all be contributing factors.

Steven Ahrendt, a surgical oncologist at the University of Colorado who was not involved in the research, said the findings came as no surprise to him.

"I certainly see patients in their 20s and 30s who have advanced appendix tumours that we take care of," he said, commenting on the team's most recent study.

"We know that colon cancer has been increasing in incidence in young adults, so it stands to reason that the same factors are operating in patients with appendix cancer," he added.

A broader trend in early-onset cancer

The findings sit within a wider pattern of rising cancer rates among younger people. A 2023 study found that the rate of cancer diagnoses in adults under 50 had jumped by nearly 80 per cent over three decades.

A 2022 international review identified gastrointestinal cancers as the most prominent category, with the sharpest increases recorded in cancers of the bowel, appendix, bile duct and pancreas.

Whilst the precise causes have yet to be established, experts have pointed to diet and poor sleep as potential contributors, with ultra-processed foods and alcohol drawing particular scrutiny.

So-called forever chemicals in drinking water and the presence of microplastics have also been linked more broadly to cancer risk.

Holowatyj and her team remain committed to building a clearer picture of who is most at risk and why.

"As a rare cancer, appendix cancer garners limited attention. Our team is passionately committed to driving marked advances in our understanding of this disease for our patients," she wrote on her Vanderbilt laboratory website.

The studies were published in Gastroenterology and the Annals of Internal Medicine.